Lien-Lung Sheu

Title: Lien-Lung Sheu: Innovator in Inhaled Anesthetic Agent Therapy

Introduction

Lien-Lung Sheu is a notable inventor based in Berkeley Heights, NJ (US). She has made significant contributions to the field of anesthesiology through her innovative patent related to inhaled anesthetic agents. Her work focuses on improving patient care in intensive care settings.

Latest Patents

Lien-Lung Sheu holds a patent for an "Inhaled Anesthetic Agent Therapy and Delivery System." This therapy utilizes inhaled anesthetic agents such as desflurane, sevoflurane, isoflurane, or xenon for the sedation of patients outside of the immediate perioperative space. The system is designed for use in medical intensive care units (MICU) and surgical intensive care units (SICU). It includes controlled delivery of volatile anesthetic agents to patients undergoing ventilatory support on an ICU ventilator over extended periods. The delivery system comprises an anesthetic agent vaporizer element, an anesthetic agent reflector, and a plug-in cassette that contains both a cartridge housing liquid phase volatile anesthetic agent and an anesthetic vapor scrubbing medium.

Career Highlights

Throughout her career, Lien-Lung Sheu has worked with prominent companies in the healthcare sector, including Baxter International Inc. and Baxter Healthcare. Her experience in these organizations has contributed to her expertise in anesthetic delivery systems.

Collaborations

She has collaborated with notable professionals in her field, including Craig T. Flanagan and William S. Hurst. These collaborations have further enhanced her research and development efforts in anesthetic therapies.

Conclusion

Lien-Lung Sheu's innovative work in inhaled anesthetic agent therapy has the potential to significantly improve patient outcomes in intensive care settings. Her contributions to the field of anesthesiology are commendable and reflect her dedication to advancing medical technology.